Friday, May 17, 2024
46.0°F

FDA chief: COVID, mail mix-up delayed action on baby formula

by MATTHEW PERRONE AP Health Writer
| May 25, 2022 9:30 AM

WASHINGTON (AP) — The head of the Food and Drug Administration said Wednesday that efforts to investigate problems at a baby formula plant linked to the nationwide shortage were slowed by COVID-19, scheduling conflicts and even a missing piece of mail.

FDA Commissioner Robert Califf laid out a series of setbacks in congressional testimony that slowed his agency's response by months, including a whistleblower complaint that didn't reach FDA leadership due to a "mailroom failure...

Support Local News

You have read all of your free articles this month. Select a plan below to start your subscription today.

Already a subscriber? Login

Daily Inter Lake - everything
Print delivery, e-edition and unlimited website access
  • $26.24 per month
Buy
Daily Inter Lake - unlimited website access

  • $9.95 per month
Buy
CLICK HERE FOR E-EDITION OPTION, $16.10 PER MONTH